Equities Research Analysts’ updated eps estimates for Thursday, July 25th:
Afentra (LON:AET) had its not rated rating reissued by analysts at Shore Capital.
Alkermes (NASDAQ:ALKS) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $48.00 target price on the stock.
Aptitude Software Group (LON:APTD) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 470 ($6.08) target price on the stock.
ASGN (NYSE:ASGN) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $115.00 target price on the stock.
Alphatec (NASDAQ:ATEC) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $25.00 price target on the stock.
Avon Protection (LON:AVON) had its hold rating reiterated by analysts at Shore Capital.
AstraZeneca (LON:AZN) had its buy rating reissued by analysts at Shore Capital.
BAE Systems (LON:BA) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a GBX 1,500 ($19.40) price target on the stock.
British Land (LON:BLND) had its neutral rating reissued by analysts at Citigroup Inc..
BioMarin Pharmaceutical (NASDAQ:BMRN) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $89.00 target price on the stock.
Popular (NASDAQ:BPOP) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $120.00 target price on the stock, up from their previous target price of $110.00.
Boston Scientific (NYSE:BSX) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $85.00 target price on the stock.
First Busey (NASDAQ:BUSE) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $31.00 price target on the stock, up from their previous price target of $28.00.
Centamin (LON:CEY) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 150 ($1.94) price target on the stock.
Check Point Software Technologies (NASDAQ:CHKP) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Check Point Software Technologies (NASDAQ:CHKP) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $200.00 target price on the stock, up from their previous target price of $175.00.
Clearside Biomedical (NASDAQ:CLSD) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $4.00 target price on the stock.
CMC Markets (LON:CMCX) had its hold rating reaffirmed by analysts at Shore Capital.
Capital One Financial (NYSE:COF) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $150.00 target price on the stock.
CervoMed (NASDAQ:CRVO) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $65.00 price target on the stock.
CVS Group (LON:CVSG) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 2,370 ($30.65) target price on the stock.
Diebold Nixdorf (NYSE:DBD) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $50.00 price target on the stock.
Everyman Media Group (LON:EMAN) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 200 ($2.59) target price on the stock.
Edgewise Therapeutics (NASDAQ:EWTX) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $32.00 target price on the stock.
Farmers National Banc (NASDAQ:FMNB) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $15.00 target price on the stock, up from their previous target price of $14.00.
General Dynamics (NYSE:GD) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $320.00 price target on the stock.
Goosehead Insurance (NASDAQ:GSHD) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $80.00 price target on the stock.
Invinity Energy Systems (LON:IES) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 65 ($0.84) target price on the stock.
IG Group (LON:IGG) had its buy rating reiterated by analysts at Shore Capital.
ITV (LON:ITV) had its buy rating reaffirmed by analysts at Shore Capital.
Judges Scientific (LON:JDG) had its house stock rating reiterated by analysts at Shore Capital.
JTC (LON:JTC) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,150 ($14.87) price target on the stock.
Strix Group (LON:KETL) had its hold rating reiterated by analysts at Shore Capital.
KLA (NASDAQ:KLAC) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $950.00 price target on the stock.
LKQ (NASDAQ:LKQ) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $60.00 target price on the stock.
Lloyds Banking Group (LON:LLOY) had its hold rating reiterated by analysts at Shore Capital.
Mitchells & Butlers (LON:MAB) had its buy rating reiterated by analysts at Shore Capital.
Moelis & Company (NYSE:MC) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $60.00 price target on the stock, up from their previous price target of $54.00.
Monarch Casino & Resort (NASDAQ:MCRI) had its neutral rating reiterated by analysts at Macquarie. Macquarie currently has a $76.00 price target on the stock.
Middleby (NASDAQ:MIDD) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $159.00 target price on the stock.
Mony Group (LON:MONY) had its buy rating reaffirmed by analysts at Shore Capital.
Merus (NASDAQ:MRUS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $67.00 price target on the stock.
Matador Resources (NYSE:MTDR) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $75.00 target price on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Neurocrine Biosciences (NASDAQ:NBIX) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $155.00 price target on the stock.
Nabors Industries (NYSE:NBR) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $114.00 target price on the stock.
ServiceNow (NYSE:NOW) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $900.00 target price on the stock.
Option Care Health (NASDAQ:OPCH) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $38.00 price target on the stock.
O’Reilly Automotive (NASDAQ:ORLY) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $1,100.00 price target on the stock.
Oatly Group (NASDAQ:OTLY) had its sector perform rating reissued by analysts at Royal Bank of Canada. They currently have a $1.05 target price on the stock.
The Pebble Group (LON:PEBB) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 150 ($1.94) target price on the stock.
The Pebble Group (LON:PEBB) had its buy rating reissued by analysts at Shore Capital.
Impinj (NASDAQ:PI) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $205.00 price target on the stock.
Impinj (NASDAQ:PI) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $195.00 target price on the stock.
PennyMac Mortgage Investment Trust (NYSE:PMT) had its neutral rating reaffirmed by analysts at Wedbush. They currently have a $15.00 price target on the stock.
Poseida Therapeutics (NASDAQ:PSTX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $20.00 target price on the stock.
Ribbon Communications (NASDAQ:RBBN) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $5.00 price target on the stock.
Rogers Communications (NYSE:RCI) (TSE:RCI.B) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $57.00 price target on the stock, down from their previous price target of $59.00.
Roku (NASDAQ:ROKU) had its outperform rating reiterated by analysts at Wedbush. They currently have a $75.00 target price on the stock.
Rollins (NYSE:ROL) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $52.00 price target on the stock.
Range Resources (NYSE:RRC) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $39.00 target price on the stock.
Sage Therapeutics (NASDAQ:SAGE) had its neutral rating reaffirmed by analysts at HC Wainwright. The firm currently has a $25.00 price target on the stock.
Softcat (LON:SCT) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a GBX 1,250 ($16.17) target price on the stock.
SDX Energy (LON:SDX) had its house stock rating reissued by analysts at Shore Capital.
SEI Investments (NASDAQ:SEIC) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $73.00 price target on the stock, down from their previous price target of $74.00.
Steven Madden (NASDAQ:SHOO) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $44.00 price target on the stock.
Silicon Laboratories (NASDAQ:SLAB) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $150.00 price target on the stock.
Stock Yards Bancorp (NASDAQ:SYBT) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $64.00 price target on the stock, up from their previous price target of $54.00.
TELA Bio (NASDAQ:TELA) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a $14.00 price target on the stock.
Teradyne (NASDAQ:TER) had its neutral rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $180.00 price target on the stock.
Tenet Healthcare (NYSE:THC) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $170.00 target price on the stock, up from their previous target price of $155.00.
Tharisa (LON:THS) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 130 ($1.68) price target on the stock.
Tri Pointe Homes (NYSE:TPH) had its neutral rating reiterated by analysts at Wedbush. The firm currently has a $42.00 price target on the stock.
Tractor Supply (NASDAQ:TSCO) had its outperform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $305.00 target price on the stock.
Trade Desk (NASDAQ:TTD) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $100.00 price target on the stock.
Tyler Technologies (NYSE:TYL) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $600.00 price target on the stock.
Universal Health Services (NYSE:UHS) had its underweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $162.00 price target on the stock.
Unite Group (LON:UTG) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a GBX 1,100 ($14.23) target price on the stock.
Vigil Neuroscience (NASDAQ:VIGL) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $17.00 price target on the stock.
Viking Therapeutics (NASDAQ:VKTX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $90.00 price target on the stock.
Receive News & Ratings for Afentra plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afentra plc and related companies with MarketBeat.com's FREE daily email newsletter.
-DORA.png?v=2023-09-05&h=45&w=95&zc=2){kind=small}
